Literature DB >> 10836978

Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells.

J Kanellis1, S Fraser, M Katerelos, D A Power.   

Abstract

Vascular endothelial growth factor (VEGF) acts primarily as an endothelial cell mitogen via the "endothelial cell-specific" receptors VEGFR-1 (flt-1) and VEGFR-2 (flk-1/KDR). Only a few nonendothelial cells have been shown to possess functional VEGF receptors. We therefore examined the rat renal tubular epithelial cell line NRK52-E. NRK52-E expressed VEGFR-1 and VEGFR-2 mRNA and protein by RT-PCR, Northern blotting, Western blotting, immunofluorescence, and ligand binding. Serum-starved NRK52-E incubated with VEGF showed a significant increase in [(3)H]thymidine incorporation compared with control (2.3-fold at 1-10 ng/ml, P < 0. 05; 3.3-fold at 50-100 ng/ml, P < 0.01). VEGF also protected NRK52-E from hydrogen peroxide-induced apoptosis and necrosis compared with control (annexin-V-FITC-positive cells, 39 vs. 54%; viable cells, 50. 5 vs. 39.7%). Immunohistochemical staining using a variety of antibodies showed expression of both VEGF receptors in normal rat renal tubules in vivo. Because VEGF induced a proliferative and an antiapoptotic response in renal tubular epithelial cells, these data suggest that VEGF may act as a survival factor for renal tubular epithelium in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836978     DOI: 10.1152/ajprenal.2000.278.6.F905

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  34 in total

1.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

2.  Unexplained fetal death: another anti-angiogenic state.

Authors:  Jimmy Espinoza; Tinnakorn Chaiworapongsa; Roberto Romero; Yeon Mee Kim; Gi Jin Kim; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Emmanuel Bujold; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  J Matern Fetal Neonatal Med       Date:  2007-07

3.  Tubular vascular endothelial growth factor-a, erythropoietin, and medullary vessels: a trio linked by hypoxia.

Authors:  Alda Tufro
Journal:  J Am Soc Nephrol       Date:  2014-11-10       Impact factor: 10.121

4.  VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition.

Authors:  Yao-guo Lian; Qiu-gen Zhou; Ying-juan Zhang; Fa-lei Zheng
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 5.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

6.  Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function.

Authors:  James A Browne; Rui Yang; Lingyun Song; Gregory E Crawford; Shih-Hsing Leir; Ann Harris
Journal:  Mol Hum Reprod       Date:  2014-09-01       Impact factor: 4.025

7.  TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.

Authors:  Weon Sup Lee; Bo-Jeong Pyun; Sung-Woo Kim; Sang Ryeol Shim; Ju Ryoung Nam; Ji Young Yoo; Younggeon Jin; Juyoun Jin; Young-Guen Kwon; Chae-Ok Yun; Do-Hyun Nam; Keunhee Oh; Dong-Sup Lee; Sang Hoon Lee; Jin-San Yoo
Journal:  MAbs       Date:  2015-05-05       Impact factor: 5.857

8.  Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression.

Authors:  Qiu-gen Zhou; Fa-lei Zheng; Fan-fan Hou
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

9.  Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.

Authors:  Ricardo Saban; Marcia R Saban; Julie Maier; Ben Fowler; Mark Tengowski; Carole A Davis; Xue-Ru Wu; Daniel J Culkin; Paul Hauser; Joseph Backer; Robert E Hurst
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

10.  Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury.

Authors:  Florian Tögel; Arthur Cohen; Ping Zhang; Ying Yang; Zhuma Hu; Christof Westenfelder
Journal:  Stem Cells Dev       Date:  2009-04       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.